As compared to other cancer types, in ccRCC, the differential activation of target genes leads to contrasting effects on cancer progression, as high HIF-2α expression enhances tumorigenic activity, whereas high HIF-1α has tumour suppressive effect [11–13]. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.